NEW YORK, Oct. 19 - PerkinElmer, which recently acquired NEN Life Sciences and inked a deal with Incyte to develop microarrays, reported Thursday a third quarter cash earning per share increase of 38 percent compared with a year ago.
...and receive Daily News bulletins.
Already have an account?Login Now.
The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.
Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.
CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.
In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.